Dr. Fayaz Shawl

About Dr. Fayaz Shawl

Dr. Fayaz Shawl is an internationally renowned Interventional Cardiologist with a distinguished career spanning more than four decades. He currently serves as Director of Interventional Cardiology at Adventist HealthCare White Oak Medical Center in Maryland, USA, and has been a Visiting Interventional Cardiologist at Zulekha Hospital Dubai since 2006.

A pioneer in modern interventional cardiology, Dr. Shawl performed the first Percutaneous Transluminal Coronary Angioplasty (PTCA) within the United States Military at Walter Reed Army Medical Center in 1981. Throughout his career, he has remained at the forefront of advancements in coronary and structural heart interventions.

Having performed over 20,000 angioplasty procedures, Dr. Shawl has contributed significantly to the evolution of minimally invasive cardiac treatments. His extensive clinical expertise, academic leadership, and groundbreaking work in interventional cardiology have established him among the best cardiologist in Dubai.

Educational Qualifications

1. MD
2. Fellow of the American College of Physicians (FACP)
3. Fellow of the American College of Cardiology (FACC)
4. Fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI)
5. Cardiology Fellowship, Walter Reed Army Medical Center, USA

Special Interests

1. Coronary: Balloon Angioplasty, Coronary Stenting, Directional Atherectomy, Rotational Atherectomy, High-Risk and Complex PCI, Cardiopulmonary Support-Assisted Angioplasty
2. Structural Heart Disease: Aortic Valvuloplasty, Mitral Valvuloplasty, Transcatheter Aortic Valve Replacement (TAVR), Alcohol Septal Ablation for IHSS, PFO Closure, ASD Closure
3. Peripheral: Carotid Stenting, Subclavian, Renal, Iliac, Superficial femoral artery, Infrapopliteal, Aortic Aneurysm Repair

Research / Publications

1. Shawl FA, Editor in chief. Supported Complex and High Risk Coronary Angioplasty. Kluwer Academic Publishers, Boston, Dordrecht, London, 1991.

Book Chapters

1. Shawl FA. Percutaneous cardiopulmonary support in high risk coronary angioplasty. In: Crawford MH, ed. Cardiology Clinics. Philadelphia: WB Saunders Company, 1989:865-875.
2. Shawl FA. Percutaneous cardiopulmonary bypass support: Current technique and future directions. In Vogel RA and King, SB III (eds). The Practice of Interventional Cardiology. St. Louis, MO: Mosby--Year Book, Inc., 1993:435-456.
3. Shawl FA. Current technique and future directions of percutaneous cardiopulmonary bypass support. In Topol EJ and Serruys PW (Eds). Current Review of Interventional Cardiology. Philadelphia, PA: Current Medicine, 1994:3/1-3/19.
4. Ronan JA, Shawl FA. Echocardiographic and hemodynamic changes during percutaneous cardiopulmonary bypass support. In Shawl FA (Ed). Supported Complex and High Risk Coronary Angioplasty. Boston: Kluwer Academic Publishers, 1991:57-63.
5. Shawl FA. Percutaneous cardiopulmonary bypass support: Technique, indications and complications. In Shawl FA (Ed). Supported Complex and High Risk Coronary Angioplasty. Boston: Kluwer Academic Publishers, 1991:65-100.
6. Shawl FA. Percutaneous cardiopulmonary bypass support in patients undergoing "high risk" coronary angioplasty. In Shawl FA (Ed). Supported Complex and High Risk Coronary Angioplasty. Boston: Kluwer Academic Publishers, 1991:101-130.
7. Domanski MJ, Shawl FA. Emergency institution of cardiopulmonary bypass support in cardiogenic shock. Shawl FA (Ed). Supported Complex and High Risk Coronary Angioplasty. Boston: Kluwer Academic Publishers, 1991:131-144.
8. Shawl FA. Emergency percutaneous cardiopulmonary bypass support in patients with cardiac arrest. In Shawl FA (Ed). Supported Complex and High Risk Coronary Angioplasty. Boston: Kluwer Academic Publishers, 1991:145-165.
9. Wish MH, Shawl FA. Intraaortic balloon pump supported high risk coronary angioplasty. In Shawl FA (ed). Supported Complex and High Risk Coronary Angioplasty. Boston: Kluwer Academic Publishers, 1991:189-197.
10. Shawl FA, Baxley WA. Role of Percutaneous Cardiopulmonary Bypass and Other Support Devices in Interventional Cardiology. Roubin G and Dean L (eds). Cardiology Clinics: New Interventional Techniques 1994; 46(2):543-557. Philadelphia PA; WB Saunders Company: 1994.
11. Shawl FA. Left Ventricular Dysfunction. Ellis SG, Holmes DR (eds). Strategic Approaches in Coronary Intervention 1996; 27: 459-469.
12. Shawl FA, Aroesty JM. Circulatory Assist Devices. Baim DS, Grossman W (eds). Cardiac Catheterization, Angiography and Intervention, Fifth Edition, Philadelphia, PA, 1996; 24:p421-462.
13. Shawl FA. Elective Stenting of Extracravial Carotid Arteries Short and Mid-Term Results. Branchereau A, Jacobs M, New Trends And Developments In Carotid Artery Disease, First Edition, Armonk, NY,1998;27:p255-268.
14. Shawl F. Restenosis Following Carotid Artery Stenting. Al-Mubarak N, Iyer S, Roubin G, Vitek J, (eds). Carotid Artery Stenting: Current Practice and Techniques, Philadelphia, PA: Lippincott Williams & Wilkins, 2004; 19:p221-242.

Published Manuscripts

1. Huggins TJ, Brott WH, Shawl FA. Left atrial myxoma computed tomography as a diagnostic modality. J Comput Assist Tomogr: 1980; 4(2):253-255.
2. Shawl FA, Chun PKC. Pneumopericardial tamponade post coronary artery bypass sternal dehiscence. Am Heart J: 1982; 104:160-163.
3. Graeber GM, Shawl FA, Wolf RE, Burge JR, Cafferty RJ, Lough FC, Zajtchuk R. Changes in serum creatine kinase and lactic dehydrogenase caused by acute pre-operative myocardial infarction and by transatrial cardiac surgical procedures. J Thorac Cardiovasc Surg: 1986; 2:63-72.
4. Shawl FA, Chun PKC, Mutter ML, Donahue DT, Slama R, Davia JE, Zajtchuk R. Asymptomatic left main coronary artery disease. Am Heart J: 1989; 117:537-542.
5. Shawl FA, Domanski MJ, Hernandez TJ, Punja S. Emergency percutaneous cardiopulmonary bypass with cardiogenic shock from acute myocardial infarction. Am J Cardiol: 1989; 64:967-970.
6. Shawl FA, Domanski MJ, Hernandez TJ, Punja S. Emergency cardiopulmonary bypass support in high-risk patients undergoing percutaneous tranluminal coronary angioplasty. Am J Cardiol: 1989; 64:1258-1263.
7. Shawl, FA. Current status of aortic and mitral valvuloplasty. Monthly Cardiology Proceedings--Washington Adventist Hospital, 1989.
8. Shawl FA, Forman MB, Goldbaum TS, Punja S. Emergent coronary angioplasty in the treatment of ischemic mitral regurgitation: Long term results in five cases. J Am Coll Cardiol: 1989; 14:1986-1991.
9. Shawl FA. Percutaneous cardiopulmonary bypass support in the catheterization laboratory application in high-risk PTCA, cardiogenic shock and in cardiac arrest. Cardio: 1990:88-96.
10. Lowinger T, Shawl FA, Difee G, Richmond J. Percutaneous cardiopulmonary (bypass) support in the cardiac catheterization laboratory: A new application of perfusion. Am Soc ExCt: 1990.
11. Shawl FA. Percutaneous cardiopulmonary bypass support in high risk coronary angioplasty. Cardiology Clinics: 1989; 87; 4:865-875.
12. Shawl FA. Percutaneous cardiopulmonary bypass support in high risk interventions. J Invas Cardiol: 1989; 5:287-293.
13. Shawl FA, Domanski MJ, Wish MH, Davis M, Punja S, Hernandez TJ. Percutaneous cardiopulmonary bypass support in patients with cardiac arrest in the catheterization laboratory. Cathet Cardiovasc Diagn: 1990; 19:8-12.
14. Shawl FA, Domanski MJ, Davis M, Wish MH. Percutaneous cardiopulmonary bypass support in the catheterization laboratory: Technique and complications. Am Heart J: 1990; 120(1):195-203.
15. Shawl FA, Velasco CE, Goldbaum TS, Foreman MB. Effect of coronary angioplasty on electrocardiographic changes and mortality in patients with unstable angina secondary to left anterior descending coronary artery disease. J Am Coll Cardiol: 1990; 16(2):325-331.
16. Vogel RA, Shawl FA, Tammaso C, O´Neill W, Overlie P, O´Toole J, Vandormael M, Topol W, Tabari KK, Vogel J, Smith S Jr. Freedmann R Jr, White C, George B, Teirstein P. Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty. J Am Coll Cardiol: 1990; 15:23-29.
17. Shawl FA, Domanski MJ, Yackee JM, Wish M, Dullum M, Neimat S. Left ventricular rupture complicating percutaneous mitral commissurotomy: Salvage using percutaneous cardiopulmonary bypass support. Cathet Cardiovasc Diagn: 1990; 21:26-27.
18. Shawl FA, The ProbeTM Investigators Group. ProbeTM III Catheter, An Improved Balloon-On-A-Wire System: Initial Experience. J Inv Cardiol: 1990; 2:139-145.
19. Forman MB, Perry JM, Wilson BH, Verani MS, Kaplan PR, Shawl FA, Friesinger GC. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction. J Am Coll Cardiol 1991; 18(4):911-8.
20. Dillon ML, Jones RG, Shawl F. A nursing guide for patient care after percutaneous cardiopulmonary support. Heart Lung 1992; 21(3): 228-34.
21. Shawl FA. Minimally invasive angioplasty: an editorial. J Invas Cardiol: 1993; 5:119-121.
22. Shawl FA. Minimally invasive angioplasty: Acute and long term results of low pressure dilatation with a non-compliant balloon during percutaneous transluminal coronary angioplasty. J Invas Cardiol: 1993; 5:122-127.
23. Shawl FA. Emergent percutaneous cardiopulmonary bypass for cardiac arrest. CardioIntervention: 1993; 3(2):11-15.
24. Shawl FA. Minimally Traumatic Angioplasty. Indian Heart Journal: 1994; 46(1):1-2.
25. Shawl FA. Percutaneous Cardiopulmonary Bypass Support: Current Technique, and Indications. Indian Heart Journal: 1993; 45(6):443-449.
26. Speir E, Modali R, Huang ES, Leon MB, Shawl FA. Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis. SCIENCE: 1994; 265:391-393.
27. Shawl FA. Emergency Percutaneous Carotid Stenting during Stroke. The Lancet: 1995; 346(8984):1223.
28. Shawl FA, Quyyumi A, Bajaj S, Hoff SB, Dougherty KG. Percutaneous Cardiopulmonary Bypass-Supported Coronary Angioplasty in Patients with Unstable Angina Pectoris or Myocardial Infarction and a Left Ventricular Ejection Fraction <25%. Am J Cardiol: 1996; 77:14-19.
29. Shawl FA, Efstratiou, A, Hoff SB, Dougherty KG. Combined Percutaneous Carotid Stenting and Coronary Angioplasty During Acute Ischemic Neurologic and Coronary Syndromes. Am J Cardiology: 1996; 77:1109-1112.
30. Shawl FA. High Risk Coronary Intervention in Severe Left Ventricular Dysfunction. J Inv Cardiol: 1997; 9(1):71-77.
31. Talley JD, Shawl FA, Pichard A, M.D., Giambartolomei A. Multicenter Evaluation of Fixed-Wire PTCA Catheters with Modified Distal Tips: Initial and 2-Month Follow-Up Results. J of Interventional Cardiol: 1997; 10(4):295-299.
32. Wholey MH, Wholey M, Bergeron P, Shawl FA. Current Global Status of Carotid Artery Stent Placement. Cathet and Cardiovasc Diagn: 1998; 44:1-6.
33. Dukovcic AL, Daleiden-Burns A, Shawl F. Percutaneous cardiopulmonary support for high-risk angioplasty. Crit Care Nurs Q 1998; 20(4): 16-28. Review. Erratun in Critical Care Nurs Q 1998; 21(1): VI.
34. Dougherty KG, Daleiden-Burns A, Kaden C, Ramos S, Shawl FA. Percutaneous techniques for the treatment of cerebrovascular disease. Crit Care Nurs Q 1998; 20(4): 1-15. Review.
35. Shawl FA. Carotid Stenting in Patients with Symptomatic Coronary Artery Disease: A Preferred Approach. J Inv Cardiol: 1998; 10(7):432-442.
36. Shawl FA. Carotid artery stenting: technical considerations and results. Indian Heart J 1998; 50 Suppl 1: 138-44.
37. Shawl FA. Role of PTCA and mechanical devices in cardiogenic shock. Indian Heart J 1998; 50 Suppl 1: 57-61. Review.
38. Shawl FA, Domanski MJ; Kaul U, Dougherty KG, Hoff S, Rigali GE, Cornell SL, Shahab ST. Procedural results and early clinical outcome of percutaneous transluminal myocardial revascularization. Am J Cardiol: 1999; 83(4): 498-501. Erratum in Am J Cardiol 1999; 83(11): 1594.
39. Shawl FA. Percutaneous Transluminal Myocardial Revascularization: An Emerging Technology. J Invasive Cardiol: 1999; 11(3): 169-176.
40. Kaul U, Shawl F, Singh B, Sudan D, Sapra R, Ghose T, Dixit NS. Percutaneous transluminal myocardial revascularization with a holmium laser system: procedural results and early clinical outcome. Catheter Cardiovasc Interv: 1999; 47(3): 287-91.
41. Dullum MK, Block J, Qazi A, Shawl F, Benetti F. Xiphoid MIDCAB: report of the technique and experience with a less invasive MIDCAB procedure. Heart Surg Forum: 1999;2(1): 77-81.
42. Shawl FA. Safety and Efficacy of Elective Carotid Artery Stenting in High-Risk Patients. J Am Coll Cardiol: 2000; 35:1721-1728.
43. Wholey MH, Wholey M, Mathias K, Roubin GS, Diethrich EB, Henry M, Bailey S, Bergeron P, Dorros G, Eles G, Gaines P, Gomez CR, Gray B, Guimaraens J, Higashida R, Ho DS, Katzen B. Kambara A, Kumar V, Laborde JC, Leon M, Lim M, Londero H, Mesa J, Musacchio A, Myla S, Ramee S, Rodriquez A, Rosenfield K, Sakai N, Shawl F, Sievert H, Teitelbaum G, Theron JG, Vaclav P, Vozzi C, Yadav JS, Yoshimura SI. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv: 2000; 50(2): 160-7.
44. New G, Roubin GS, Iyer SS, Vitek JJ, Wholey MH, Diethrich EB, Hopsins LN, Hobson RW 2nd, Leon MB, Myla SV, Shawl F, Ramee SR, Yadav JS, Rosenfield K, Liu MW, Gomez CR, Al-Mubarak N, Gray WA, Tan WA, Goldstin JE, Stack RS. Safety, efficacy, and durability of carotid artery stenting for restenosis following carotid endarterectomy: a multicenter study. J Endovasc Ther: 2000; 7(5): 345-52.
45. Goldberg SL, Berger P, Cohen DJ, Shawl F, Buchbinder M, Fortuna R, O´Neill W. Leon M, Braden GA, Teirstein PS, Reisman M, Bailey SR, Dauerman HL, Bowers T, Mehran R, Colombo A. Rotational atherectomy or balloon angioplasty in the treatment of intra-stent restenosis: BARASTER multicenter registry. Catheter Cardiovasc Interv: 2000; 51(4): 407-13.
46. Shawl FA. Clinical Interventional Approaches to Inoperable Patients. Current Interv Cardiol Reports: 2001, 3: 18-27.
47. Shawl FA. Interview with Fayaz A. Shawl, MD by Laurie Gustafson. J Invasive Cardiol: 2001; 13(4): 345-52.
48. Shawl F. Clinical Interventional Approaches to Patients with Diffuse Coronary Artery Disease. IAGS Proceedings - J Inv Cardiol: 2001; 13(3): 251-4.
49. Stone GW, StGoar FG, Taussig A, Power JA, Kosinski E, Shawl F. First experience with hybrid percutaneous transmyocardial laser revascularization and angioplasty in patients with lesions at high risk for restenosis: Results of a phase I feasibility study. Am Heart J: 2001; 142(4): 679-83.
50. Overlie PA, de la Fuente L, Feltrin G, Rodriguez A, Shawl F. Supporting Patients in Shock. IAGS Proceedings/Panel Discussion - J Inv Cardiol: 2002; 14(8): 483-91.
51. Shawl FA. Carotid artery stenting: acute and long-term results. Current Opinion in Cardiology: 2002; 17(6): 671-6.
52. Whitlow PL, DeMaio SJ Jr, Perin EC, O´Neill WW, Lasala JM, Schneider JE, McKeever LS, Ezratty AM, Knopf WD, Powers ER, Shawl FA: Eclipse Investigators. One-year results of percutaneous myocardial revascularization for refractory angina pectoris. Am J Cardiol: 2003;
53. Shawl, F Lederman RJ. Prophylactic, Standby or rescue support for High Risk PCI: Who know when? J Invasive Cardiol. 2008 ;20 (2) : 73-4
54. Agarwal SK, Shawl F, Raman VK, Binbrek AS. Very Late thrombosis of drug eluting stents. J.Invasive Cardiol ; 2008 (12) : 655-8
55. A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):1001-9.
56. Mehran R1, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Berger PB, Iakovou I, Dangas G, Waksman R, Antoniucci D, Sartori S, Krucoff , Hermiller JB, Shawl F, Gibson CM, Chieffo A, Alu M, Moliterno DJ, Colombo A, Pocock. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet.2013 Nov 23;382(9906):1714-22.
57. Howard G1, Hopkins LN1, Moore WS1, Katzen BT1, Chakhtoura E1, Morris Ferguson RD1, Hye RJ1, Shawl FA, Harrigan MR1, Voeks JH1, Howard VJ1, Lal BK1, Meschia JF1, Brott TG2.Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting Trial. Stroke. 2015 Aug;46(8):2183-9.